siRNA-mediated knockdown against NUF2 suppresses pancreatic cancer proliferation in vitro and in vivo
Open Access
- 14 January 2015
- journal article
- retracted article
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 35 (1)
- https://doi.org/10.1042/bsr20140124
Abstract
NUF2 (NUF2, Ndc80 kinetochore complex component) plays an important role in kinetochore-microtubule attachment. It has been reported that NUF2 is associated with multiple human cancers. However, the functional role of NUF2 in pancreatic cancer remains unclear. In this study, we found that NUF2 expression was stronger in tumour tissues than in normal pancreatic tissues, and its overexpression could be related to poor prognosis. Moreover, NUF2 was highly expressed in several human pancreatic cancer cell lines. We took advantage of lentivirus-mediated siRNA (small interfering RNA) to suppress NUF2 expression in PANC-1 and Sw1990 cell lines aiming to investigate the role of NUF2 in pancreatic cancer. NUF2 silencing by RANi (RNA interference) reduced the proliferation and colony formation ability of pancreatic cancer cells in vitro. Cell cycle analysis showed that NUF2 knockdown induced cell cycle arrest at G0/G1 phase via suppression of Cyclin B1, Cdc2 and Cdc25A. More importantly, NUF2 silencing was able to alleviate in vivo tumourigenesis in pancreatic cancer xenograft nude mice. Collectively, the present study indicates that the siRNA-mediated knockdown against NUF2 may be a promising therapeutic method for the treatment of pancreatic cancer.Keywords
This publication has 33 references indexed in Scilit:
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Postresection Surveillance for Pancreatic Cancer Performance Status, Imaging, and Serum MarkersThe Cancer Journal, 2012
- An RNA Interference Lethality Screen of the Human Druggable Genome to Identify Molecular Vulnerabilities in Epithelial Ovarian CancerPLOS ONE, 2012
- Collateral sensitivity as a strategy against cancer multidrug resistanceDrug Resistance Updates, 2012
- Cancer/Testis antigens as potential predictors of biochemical recurrence of prostate cancer following radical prostatectomyJournal of Translational Medicine, 2011
- Distant metastasis occurs late during the genetic evolution of pancreatic cancerNature, 2010
- siRNA-mediated knockdown against CDCA1 and KNTC2, both frequently overexpressed in colorectal and gastric cancers, suppresses cell proliferation and induces apoptosisBiochemical and Biophysical Research Communications, 2009
- Small Molecule Targeting the Hec1/Nek2 Mitotic Pathway Suppresses Tumor Cell Growth in Culture and in AnimalCancer Research, 2008
- Improved anti-tumor therapy based upon infectivity-enhanced adenoviral delivery of RNA interference in ovarian carcinoma cell linesGynecologic Oncology, 2008
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001